SCHEMBL80492

SCHEMBL80492

CC1(C)OBOC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31409638 0.95
SCHEMBL17686774 0.84
SCHEMBL14795773 0.82
Phosphoric Acid SCHEMBL31203368 0.77 SLC34A1 (0.30)
SCHEMBL15711508 0.73
SCHEMBL13347441 0.70
SCHEMBL19047362 0.61
SCHEMBL1024758 0.60
SCHEMBL6569977 0.56
SCHEMBL4271079 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7407 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595247-B2 Substituted pyrazolo piperidine carboxylic acids BAYER AKTIENGESELLSCHAFT (DE) 2026-04-07 US claimed
US-20250206724-A1 SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2025-06-26 US claimed
EP-4574828-A2 PROCESS FOR PREPARING BTK INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-06-25 EP claimed
EP-4573100-A1 SYNTHESIS OF SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS AND SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND ANALOGUES THEREOF Arbutus Biopharma Corporation (CA) 2025-06-25 EP claimed
EP-4499612-A1 SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2025-02-05 EP claimed
US-12195448-B2 Substituted pyrazolo piperidine carboxylic acids BAYER AKTIENGESELLSCHAFT (DE) 2025-01-14 US claimed
EP-4334311-B1 PROCESS FOR PREPARING BTK INHIBITORS HOFFMANN LA ROCHE (CH) 2024-12-25 EP claimed
EP-3814340-B1 NOVEL CATECHOL DERIVATIVES OR SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME HEXAPHARMATEC CO LTD (KR) 2024-12-18 EP claimed
US-20240360147-A1 Process for Synthesizing Naphthyridine Derivatives and Intermediates Thereof AMGEN INC. 2024-10-31 US claimed
US-12084454-B2 Process for preparing BTK inhibitors HOFFMANN-LA ROCHE INC. (US) 2024-09-10 US claimed
WO-2007022437-A2 THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND METABOLIC DISORDERS AUSPEX PHARMACEUTICALS, INC. (US) 2007-02-22 WO claimed
US-7122694-B2 Hydroboronation process BORON MOLECULAR PTY LIMITED (AU) 2006-10-17 US claimed
WO-2006086657-A1 PROCESS FOR PREPARING 2,3-DISUBSTITUTED INDOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-08-17 WO claimed
US-20060183752-A1 Process for preparing 2, 3-disubstituted indoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-08-17 US claimed
EP-1127060-B8 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2005-01-05 EP claimed
US-20040133028-A1 Hydroboronation process COMMONWEALTH SCIENTIFIC 2004-07-08 US claimed
EP-1127060-B1 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2004-04-07 EP claimed
EP-1127060-A4 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2002-08-21 EP claimed
EP-1127060-A1 HYDROBORONATION PROCESS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2001-08-29 EP claimed
WO-2000027853-A1 HYDROBORONATION PROCESS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2000-05-18 WO claimed